Publicly traded stocks of Canadian marijuana companies headed higher Tuesday after a federal task force issued recommendations on the sale of recreational pot.
On the TSX, shares of Canada’s largest producer, Canopy Growth — the first pot company with a market capitalization above $1 billion — rose 79 cents, or 7.9 per cent, to close at $10.79, its high for the day..
Among the smaller companies, Emerald Health Therapeutics shares rose 15 cents, or 12 per cent,to reach $1.40 on the TSX Venture Exchange.
Shares of Aphria Inc., a producer and seller, increased by more than five per cent to hit $5.34, while Mettrum Health Corp. shares increased by 7.7 per cent to end at at $7.16.
CBC News – Dec 13, 2016.
Want More Investigative Content?
